Brief: Silk Road Medical Reports Third Quarter 2022 Financial Results
Nov 8 (Reuters) - Silk Road Medical Inc SILK.O :
* SILK ROAD MEDICAL REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* REVENUE FOR Q3 OF 2022 WAS $37.4 MILLION, AN INCREASE OF
$12.7
MILLION, OR 51%, COMPARED TO Q3 OF 2021
* QTRLY LOSS PER SHARE $0.29
* SEES REVENUE FOR FULL YEAR 2022 TO RANGE FROM $134 MILLION
TO
$137 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.43, REVENUE VIEW $33.6
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $130.6 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX75yY3W
Further company coverage: SILK.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Silk Road Medical
See all newsBrief: Silk Road Medical Boston Scientific To Be Required To Pay Co Termination Fee Of $69.5 Million If Merger Agreement Terminated Under Certain Circumstances
Boston Scientific to buy Silk Road Medical in $1.16 billion deal (updated)
Brief: Boston Scientific Announces Agreement to Acquire Silk Road Medical
Brief: Silk Road Medical Announces Definitive Agreement To Be Acquired By Boston Scientific
Boston Scientific to buy Silk Road Medical for $1.16 billion